Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01168804Phase 2Completed
- Sponsor
- Austrian Forum Against Cancer
- Start
- Jun 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by Austrian Forum Against Cancer. Started Jun 2010; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01168804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01168804.